Challenges related to the stability, delivery, and large-scale production of RNA therapeutics continue to hinder progress in this field. However, advanced analytical tools, such as Droplet Digital™ PCR, are helping researchers assess RNA integrity, detect contaminants, and optimize critical parameters during various stages of RNA development. This is accelerating the development process and improving therapeutic efficacy.
Download the full white paper to learn:
- How RNA therapeutics are addressing previously undruggable diseases through innovative gene modulation strategies
- Why precision tools like Droplet Digital™ PCR are essential for evaluating RNA integrity, stability, and therapeutic effectiveness.
- The latest advancements in RNA production and quality control aimed at scaling from discovery to commercialization.
